Ann: Proteomics International seeks FDA approval for PromarkerD, page-159

Another brilliant day for us all PIQ People!

@no vice, sounds very nice re a catch up, might be a bit tricky with many of us living across different states etc, COVID-19 to plan things at the moment, but I know you did mean later down the track.

I too would like to meet the folk here we have been communicating with over the last couple of years, but I think online, you even get the gist of a great bunch of people, & I have been very grateful for some of them over some difficult times in the past 3 years. So I’m in...I would be happy with a nice beer garden lunch at a local that serves some nice food (preferably also seafood), in a nice environment & comfortable, just like this board has been over the last few years. Doesn’t need to be exclusive or expensive.

Some great posts here today, thanks all for the info, very much appreciated.

@BTB whether you think you have enough shares or not, I still believe you got in on perfect timing, although it may not have appeared that way on & off for a bit. You must be up over 100% now, so regardless, you must be pretty happy!

Unlike the poster recently who said he wasn’t happy with himself for procrastinating & not buying from high sixties to eighties, but at the time you could understand why, up & down like a yo-yo! (Will it go up, or down?) a big difference in your portfolio in a day, & I guess if you aren’t 100% over where PIQ are at, the clinical spaces & also what has been holding back PIQ in major lab deals with COVID-19 & a focus on keep on top of COVID-19 testing (Northern Hemisphere) elaborated on by the company as well (that’s real, core business has been neglected by many Tier 1 labs) & reduced analytics revenue with clinical trials on hold, at that point in time, some investors may not have wanted to take that risk.

It now appears that the right people are buying (who actually understand the company & IP) & solid moving north from $1 now, in leaps & bounds!

GLTAH